The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D003550:Cystic Fibrosis / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D007158:Immunologic Techniques; D011014:Pneumonia / Q000188:drug therapy / Q000209:etiology; D011552:Pseudomonas Infections / Q000276:immunology; D011817:Rabbits; D051381:Rats; D012141:Respiratory Tract Infections / Q000188:drug therapy / Q000209:etiology*; D013183:Sputum / Q000382:microbiology; D013203:Staphylococcal Infections / Q000276:immunology
D000900:Anti-Bacterial Agents